Cite
Sevigny J, Chiao P, Bussière T, et al. Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature. 2017;546(7659):564doi: 10.1038/nature22809.
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., O'Gorman, J., Qian, F., Arastu, M., Li, M., Chollate, S., Brennan, M. S., Quintero-Monzon, O., Scannevin, R. H., Arnold, H. M., Engber, T., Rhodes, K., Ferrero, J., Hang, Y., Mikulskis, A., Grimm, J., Hock, C., Nitsch, R. M., & Sandrock, A. (2017). Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature, 546(7659), 564. https://doi.org/10.1038/nature22809
Sevigny, Jeff, et al. "Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease." Nature vol. 546,7659 (2017): 564. doi: https://doi.org/10.1038/nature22809
Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A. Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature. 2017 Jun 21;546(7659):564. doi: 10.1038/nature22809. PMID: 28640269.
Copy
Download .nbib